The groundbreaking therapy of this peptide represents a major development in the handling of the condition. Unlike existing therapies, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatidepeptide172334.blogdun.com/42732436/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment